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Recent "udi" from our I.bornto"''' 
have attempted to clarify the events of 
hyperacute heterograft and homograft rejec-
tion.1 , 7, 15, 17, 18 These investigations, as 
well as those from other laboratories,3, 5, 6, 14 
have emphasized the complexity of this ful-
minating variety of rejection as well as the 
nearly simultaneous contributing roles played 
by preformed humoral antibodies, coagula-
tion, formed blood elements, and comple-
ment. 
It might be anticipated that therapy which 
interfered with the foregoing etiologic fac-
tors could mitigate the vigor of hyperacute 
rejection. Furthermore, if heterografts and 
homografts transplanted to naturally or de-
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liberately presensitized recIpIents undergo 
rejection by analogous mechanisms, success-
ful treatment under either of these 
experimental conditions should be applicable 
to both. In this communication, it will be 
shown that sodium citrate, a calcium-binding 
agent, has the same type of ameliorating ef-
fect upon heterograft rejection as has already 
been reported by Linn and associatesll upon 
hyperacute homograft rejection. Since free 
calcium ions are required for coagulation, 
for complement activation, and for a number 
of other biologic processes, it cannot be 
stated unequivocally by what means the pro-
tection occurred. 
METHODS 
Heterotransplantation. Twenty-two pig-to-
dog kidney heterotransplantations were per-
formed while the animals were under 
sodium pentobarbital anesthesia; the renal 
artery was anastomosed end to end to the 
recipient right common iliac artery and the 
renal vein was anastomosed end to side to 
the right common iliac vein (Fig. 1, A). A 
Teflon catheter was introduced into the right 
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Fig. 1. Procedures used for intra-arterial citrate infusion. A, Heterograft experiments and B, 
homograft experiments in sensitized recipients. 
hypogastric vein and its tip positioned oppo-
site to the venous anastomosis. By temporar-
ily clamping the iliac vein below and above 
the anastomosis, the investigators could col-
lect and measure the total venous effluent 
of the homograft (per unit time) with a 
stopwatch and a graduated cylinder (Fig. 
1, A). 
The experimental technique was designed 
to permit measurement of blood pressure in 
the distal aorta and to assure that fluid in-
fused into the terminal aorta would pass 
mainly or exclusively into the graft renal 
artery (Fig. 1, A). This was done by insert-
ing perfusion and pressure catheters proxi-
mally toward the orifices of the common iliac 
and middle sacral arteries with ligation of 
these vessels near their origin (Fig. 1, A). 
All smaller vessels originating at or near the 
aortic trifurcation were also ligated. 
In 15 of the 22 dogs, the intra-arterial 
infusion was with a solution that contained 
13.7 Gm. of sodium citrate and 13 Gm. of 
dextrose per liter of distilled water (sodium 
concentration, 140 mEq. per liter). The in-
fusion was started one minute before hetero-
graft revascularization and maintained at 
0.75 ml. per kilogram per minute (10.3 mg. 
of citrate per kilogram per minute). The 
seven other animals served as control experi-
ments and received: no infusion (one) , 
normotonic saline infusion of the same fluid 
volume (one), heparinized normotonic sa-
line solution delivering 2 mg. of heparin per 
kilogram per minute (two) or 40 mg. of 
heparin per kilogram per minute (two), and 
infusion with the above described sodium 
citrate solution to which 5 ml. of a ten per-
cent calcium chloride solution were added 
per 100 ml. (one). In the four heparin ex-
periments, an additional 5 mg. per kilogram 
(two experiments) or 100 mg. per kilogram 
(two experiments) of heparin were given 
intravenously before either graft revasculari-
zation or institution of the intra-arterial in-
fusion. 
Arteriovenous gradients of formed blood 
elements, fibrinogen, and whole complement 
were determined across the heterotransplants 
by methods previously reported.7 In addi-
tion, arterial and venous calcium and total 
protein concentrations were measured with 
a spectrophotometer and a refractometer,* 
respectively. The arterial samples were taken 
from the abdominal aorta at some distance 
above the trifurcation, and the venous sam-
ples were collected during transient occlu-
sion of the common and external iliac veins 
(Fig. 1, A). 
In four of the 15 citrate experiments and 
in all four of the heparin experiments, serial 
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biopsies were obtained from 5 to 75 and from 
5 to 20 minutes, respectively. Biopsies were 
taken prior to and after discontinuation of 
the citrate infusion. A portion of the speci-
mens was fixed in formalin and stained with 
hematoxylin and eosin and periodic acid-
Schiff (PAS). The rest was snap-frozen and 
studied by direct immunoftuorescence.21 
Homotransplantation. Eleven mongrel 
dogs were grafted six to eight consecutive 
times with skin from an eventual kidney 
donor. 1. 15 Then one of the donor kidneys 
was transplanted to the neck for 24 hours 
by means of an as tomoses to the common 
carotid artery and external jugular vein. At 
a final experiment carried out an average of 
61 days after beginning sensitization and 7 
to 11 days after the first renal homotrans-
plantation, the other donor kidney was trans-
planted to the iliac vessels of the pelvis of 
the recipient; urine was collected via a skin 
ureterostomy. At the sites of the rejected 
skin grafts or first kidney, all dogs developed 
severe infections. Four animals died before 
the investigation could be completed, leaving 
seven of which three and four were used for 
controls and for citrate evaluation, respec-
tively. In all seven dogs, antidonor hemag-
glutinins, leukoagglutinins, lymphocyto-
toxins, and thromboagglutinins were mea-
sured in systemic venous blood throughout 
the sensitization period, as described pre-
viously.l. 15 Before and after the final renal 
transplantation, hematocrit, pH, total pro-
tein, sodium, chloride, and total calcium 
were determined in central venous samples; 
arterial samples were not obtained. Rejection 
was judged by gross appearance, cessation of 
urine excretion, and the state of bleeding 
from the incised organ. Blood urea nitrogen 
and creatinine were measured in animals 
living for one day or longer after the defini-
tive renal transplantation. Biopsies were 
taken from the first kidneys at the time of 
removal 24 hours after transplantation and 
from the second kidneys after rejection had 
occurred or at the time of death. A portion 
of the specimens were fixed in formalin and 
stained with hematoxylin and eosin and pe-
riodic acid-Schiff (PAS). The rest was snap-
frozen for study by direct immunofluores-
cence. 21 
At the time of the second renal homo-
transplantation, bilateral recipient nephrec-
tomies were performed. The details of the 
homograft infusion procedure for both the 
control and treated dogs are shown in Fig. 
1, B. A catheter was inserted through a left 
lumbar artery, advanced across the aorta and 
common iliac artery, until the iliac-renal 
arterial anastomosis could be performed 
around it. These manipulations were during 
temporary aortic cross-clamping. The citrate 
solution and its rate of infusion were the 
same as in the heterograft experiments, start-
ing one minute before revascularization. The 
average water load was 1,200 m!. and the 
average sodium load was 168 mEq. during 
the two hours of treatment. The same infu-
sion was repeated six hours after revasculari-
zation. 
The procedure in the three control ex-
periments differed in that approximately 400 
m!. of citrate infusion was begun from 15 to 
35 minutes after revascularization by which 
time the homografts had already been re-
jected. More than 400 m!. could not be given 
to these anuric control animals because of 
the production of hypotension, arrhythmia, 
pulmonary edema, and acidosis. In the three 
control as well as the four test animals, 3 
Gm. of calcium chloride were given intra-
venously to prevent cardiac arrest. 
RESULTS 
Heterotransplantation. 
Control studies. The seven control pig 
kidneys were rejected by the dogs in three 
to ten minutes with a mean urinary output 
of 6 m!. The events of the hyperacute rejec-
tion were the same as have been described 
in detail by Giles and associates1 in a previ-
ous paper. Five minutes after revasculariza-
tion, arteriovenous gradients (Fig. 2) were 
observed for leukocytes (33 percent of the 
arterial value) , platelets (62 percent) , 
fibrinogen (33 percent), total protein (25 
percent), total calcium (52 percent), and 
whole complement (65 percent). These 
gradients were essentially the same in the 
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Fig. 2. Pig-to-dog kidney heterotransplantation. Arteriovenous gradients ± S.E. in control and 
citrate-treated animals at five minutes after rcvascularization. 
four heparin experiments as in the non-
heparin control experiments, despite the 
massive doses. It was also noteworthy that 
the kidney underwent almost immediate re-
jection during perfusion with citrate solu-
tion to which calcium chloride had been 
added. 
Citrate treatment. In contrast, the kidneys 
infused with citrate did not lose their initial 
pink color. These organs remained firm and 
continued to produce urine as long as the 
infusion was maintained (30 to 240 min-
utes). When the citrate infusion was dis-
continued, the kidneys were rejected within 
5 to 25 minutes. Mean rejection time of the 
15 citrate-treated kidneys was 85 minutes 
with a mean urinary output of 108 ml. 
During the citrate infusion, the average 
arterial blood pressure decreased from an ini-
tial mean of 126 to 78 mm. Hg two hours 
later in animals treated that long. Part of 
the relative hypotension was probably expli-
cable by blood loss since transfusions were 
not given, but the citrate itself undoubtedly 
also contributed.2 During this time, renal 
blood flow decreased from a mean of 74 to 
36 m!. per minute. Renal vascular resistance, 
computed as an expression of mean blood 
pressure/renal blood flow was increased 30 
percent over the original value. 
The arterial samples were taken proximal 
to the site of citrate infusion. Because of the 
more distal infusion of significant volumes of 
the citrate solution (which accounted for 
almost 20 percent of the fluid flow through 
the kidney), decreases in the concentrations 
of the various measured substances in the 
venous effluent would be predicted on a 
dilutional basis unless a brisk urinary output 
were able to excrete all the infused solution, 
which was never the case. This dilutional 
factor apparently accounted for most of the 
declines in hematocrit (Fig. 2). In contrast, 
higher gradients not explicable by this 
mechanism developed in the levels of leuko-
cytes, platelets, fibrinogen, calcium, protein, 
and whole complement (Figs. 2 and 3). 
Sequestration of the latter blood constituents 
apparently continued throughout the entire 
period of observation (Fig. 3). With cal-
cium, part of the arteriovenous gradient 
could have been accounted for by urinary 
excretion of calcium, particularly since the 
average urine volume was 108 ml. However, 
the range of calcium in this urine was 6.4 
to 23.8 mg. percent, a value not nearly high 
enough to account for all of the calcium 
gradients. 
It was of interest in the citrate experi-
ments to compare the five-minute gradients 
with those of the control experiments at the 
same time. The gradients expressed as the 
percentage of the arterial values were not 
significantly different from those in the con-
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Fig. 3. Arteriovenous gradients ± S.E. of hematocrit, white blood cell count, platelets, fibrino-
gen, total protein, total calcium, and whole complement before and at 5, 30, 60, and 120 
minutes after pig-to-dog kidney heterotransplantation under citrate treatment. 
trol experiments except for a strikingly less 
prominent complement consumption (Fig. 
2). Comparisons of the calcium gradients 
across the citrate-protected heterografts as 
opposed to the control grafts were partly 
invalidated by the fact that the former kid-
neys excreted large amounts of urine, where-
as the latter ones did not. 
Immunofluorescence studies. The im-
munofluorescence findings in hyperacutely 
rejecting pig-to-dog heterografts have been 
described in detail by Giles and associates.' 
The previous studies showed fibrin accumula-
tion beginning within three minutes, becom-
ing maximum in about ten minutes, and with 
localization in the lumens of glomerular and 
peri tubular capillaries. Dog IgG and C3 
were in a similar pattern. 
In the present investigation, essentially the 
same findings were seen in the four hetero-
grafts that were transplanted to heparinized 
recipients. In contrast, fibrin, IgG, and com-
plement deposition were retarded in three of 
the four grafts treated with citrate (Fig. 4). 
However, after discontinuance of the citrate 
infusion, deposits of these substances quickly 
developed as the organs undenvent grossly 
visible rejection (Fig. 4, C). 
Homotransplantation. 
Control studies. By the time of the first 
renal homotransplantation, a high degree of 
sensitization had already been achieved since 
six of these seven kidneys were rejected in 
less than 24 hours. The three control ani-
mals which subsequently received the second 
kidneys without benefit of citrate protection 
108 Ku.'( ct al. Surgery 
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Fig. 4. Fibrin deposits in the capillari of a glomerulus and the peri tubular area in a pig 
kidney transplanted to a citrate-treated dog. A and B, during infusion of citrate five and ten 
minutes after revascularization . C, five minutes after discontinuance of citrate and 40 minutes 
after r.,vascularization. Heavy fibrin disposition occurred as the kidney underwent gross ly 
visible rejection. 
rejected the homografts m 14, 20, and 35 
minutes (Table I). The rapidity of homo-
graft rejection in the control experiments 
was striking and considerably faster than in 
similar experimental conditions as reported 
by Simpson and associates,'" MacDonald 
and associates,12 and Boehmig and asso-
ciates. ' This was apparently due to the very 
extensive and prolonged sensitization over 
the nine-week period. Additional sensitiza-
tion may have occurred through cross-react-
ing bacterial antigens from the chronic in-
fections at the sites of rejecting skin and 
kidney grafts. 
CitTate treatment. In contrast, graft Vla-
bility in the four dogs of the citrate group 
was very much prolonged and in two in-
stances rejection had not occurred when the 
experiments were terminated after 24 and 
48 hours (Table I ). The difference in re-
sults between the control experiments was 
not due to any obvious difference in the pre-
fom1ed antibodies in the two groups (T able 
I) . 
The renal function from the citrate-pro-
tected renal homografts was not accurately 
assessed because the ureterostomy urine col-
kctions proved unreliable. However, unne 
excretion was obvious during the times 
shown in T able I, and in animals No. 6 and 
10, the blood urea nitrogen and creatmme 
remained normal until death. A brisk diure-
sis during the infusions was probably respon-
sible for the fact that citrate toxicity was less 
severe than in the control animals (see be-
low ) . 
Citrate toxicity. There was marked toxicity 
from the ci trate infusion in both the control 
and test animals in spite of prophylactic treat-
ment with 3 Gm. of calcium chloride. A 
pronounced bleeding tendency was invaria-
bly observed which usually subsided about 
an hour after stopping infusion . Profound 
hypotension, cardiac arrhythmias, and brady-
cardia were invariable. All three of the con-
trol animals and two of the four test animals 
died of the cardiovascular complications. The 
animals with poor or absent renal function 
were unable to correct the iatrogenic abnor-
malities and consequently were much more 
susceptible to the various side effects which 
included severe acidosis. In addition, they 
developed hemodilution and, during treat-
ment with calcium chloride, hyper-
calcemia (to 17.3 mg. percent ) was 
observed. 
1 mmunofiuorescence studies. Through an 
accident , all the frozen tissues from these 
experiments were thawed and were unsuit-
able for examination. 
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Table I. Outcome after renal transplantation to presensitized reczpzents at the time 
of the second renal homotransplantation, in relation to the preformed antibody 
titers (expressed as reciprocal of dilution) 
Experiment Lympho- Hemag- Leukoag- l'hromboag- Rejection 
No. eytotoxins glutinins glutinins glutinins* time 
Control animals 
2 128 4 32 8 14 mm. 
7 256 2 0 4 20 mIn. 
8 0 0 0 2 35 D11n. 
Citrate-treated animals 
3 256 8 4 8 7 hr. 
6 2 32 8 32 24t hr. 
9 64 0 4 2 6.5 hr. 
10 64 32 0 2 48t hr. 
*Thromboagglutinins were present even before sensitization in four of these seven dogs. In contrast, the lymphocytotoxins, 
hemagglutinins, and leukoagglutinins deYcloped in response to the sensitization. 
tRcjcction had not occurred when the homograft was removed. 
DISCUSSION 
It has been recently emphasized1 , 7, 12, 14, 
1", 17, 18 that hyperacute rejection is not 
necessarily due to the direct toxic action of 
antibodies upon parenchymal cells, but that 
it may be in part dependent upon antibody-
mediated effector mechanisms that jeopar-
dize the blood supply of the graft. In the 
present investigation, an attempt was made to 
interrupt these effector systems, particularly 
coagulation. The value of heparin for the 
latter purpose in presensitized recipients of 
renal homografts was previously de-
seribedY, 18 However, Giles and associates7 
were unable to see any benefit from systemic 
heparin in the difficult pig-to-dog renal 
heterotransplantation. The same observations 
were made with the heterografts of the pres-
ent study. 
In contrast, intra-arterial infusions of large 
quantities of sodium citrate delayed or pre-
vented hyperacute heterograft rejection in 
a very dramatic way as has been claimed by 
Linn and associates,u Homograft rejection 
was similarly influenced. Profound coagula-
tion defects were produced by this therapy, 
but it is by no means certain that the protec-
tion obtained was due solely or even prin-
cipally to anticoagulation, since citrate has 
many other metabolic effects. It can inhibit 
complement,9 deaggregate platelets,13 pre-
vent the vascular lesions of E. coli endo-
toxin,8 slow the release of histamine from 
leukocytes,10 paralyze a wide range of 
enzyme activity,lO and decrease smooth 
muscle contraction.19 
Of these actions, the effect on comple-
ment may be the most significant since the 
inhibition of complement has been shown 
to delay accelerated rejection under other 
experimental circumstances5 , 16 not involv-
ing anticoagulation. It was noteworthy that 
complement uptake by the heterografts was 
greatly reduced by intra-arterial citrate in-
fusion (Fig. 2) and that this was the most 
striking effect of citrate that could be identi-
fied by the measurement of a variety of gra-
dients. Of course, there is no reason to ex-
clude the possibility that the citrate effect 
was by more than one pathway. Thus, to 
anticoagulation could have been added a fur-
ther benefit from complement inhibition, 
thereby preventing or slowing a variety of 
antigen-antibody reactions at or near the 
vascular endothelium and elsewhere within 
the graft. 
In a recent publication/8 attention was 
drawn to the similarity of hyperacute kidney 
rejection to the renal findings of the general-
ized Shwartzman reaction that can be in-
duced in rabbits by the intravenous injection 
of E. coli endotoxin. Since then, there have 
been new developments in an understand-
ing of the Shwartzman reaction, indicating 
110 Kux et al. 
that desquamation of vascular endothelium 
in multiple areas may be an important lesion 
caused by endotoxin and that these areas 
could be the site of consumption of platelets, 
white cells, clotting factors, and other sub-
stances.4 Weymouth and associates20 have 
described the same kind of endothelial denu-
dation in human renal homografts within one 
hour of revascularization. The onset of the 
damage could be correlated with the onset 
and severity of acute rejection. 
It is by no means established that endothe-
lial damage is the essential lesion of either 
the Shwartzman reaction or hyperacute re-
jection. However, the point seems clearer 
with each new set of observations that 
morphologic changes in both models are 
similar. This is particularly noteworthy since 
citrate treatment has been shown to mini-
mize organ damage from the infusion of 
bacterial endotoxin8 in much the same way 
as it protects from hyperacute rejection. 
As a practical therapeutic tool, citrate has 
significant limitations. After pig-to-dog 
heterotransplantation, the discontinuance of 
citrate treatment was followed by prompt 
destruction of the transplants. The results 
were somewhat more encouraging in the 
homotransplantation experiments in which 
the kidneys functioned for as long as two 
days after initial citrate infusions. Since all 
the control homografts transplanted to sen-
sitized recipients were rejected within a few 
minutes, this finding holds some hope that 
citrate treatment could be of clinical value. 
A holdover effect would be a particularly 
important finding because of the formidable 
hazards citrate infusion presents when used 
even for short times. Those included bleed-
ing, hypotension, and cardiac arrhythmias, 
all of which were only partially controlled by 
calcium infusion. 
SUMMARY 
Hyperacute rejection was studied in seven 
presensitized canine recipients of renal homo-
grafts and in 22 canine recipients of pig 
kidneys. Under both experimental circum-
stances, untreated animals rejected the grafts 
within a few minutes. With the intra-arterial 
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infusion of sodium citrate, hyperacute 
heterograft rejection was forestalled for the 
duration of therapy, and with homografts 
the benefit outlasted treatment by many 
hours. The protection of heterografts was 
not due solely to anticoagulation by the ci-
trate, since heparin in large doses did not 
accomplish the same thing. A contributory 
factor may have been complement inhibition 
since removal of complement by the grafts 
was greatly reduced in the citrate-treated 
animals. 
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DISCUSSION 
Chairman Starz!, I would like to emphasize that 
the paper contained some information not given 
in the abstract, concerning the extension of the 
heterotransplantation findings to hypersensitized 
canine recipients of renal homografts. Further-
more, the protective effect of the citrate on the 
homografts outlasted the time of treatment, 
which was not the case in the heterografts. Dr. 
Bernie Linn was the first to describe citrate 
therapy of this kind in heterografts. I wonder if 
Dr. Linn would care to discuss this paper. 
Dr. Bernard S. Linn (Miami, Fla.): I would 
like to congratulate Dr. Kux on this fine piece of 
work. The results with homografts have a poten-
tial for clinical use that far exceeds that which I 
can see immediately for results with heterografts. 
Our own interest also began through a fortuitous 
observation several years ago, at which time, by 
mistake, we used citrated blood from dogs in-
stead of heparinized blood to prime extracorpeal 
circuits for heterograft perfusion. Hyperacute re-
jection was thereby avoided. 
I would like to make just two comments. The 
first is with regard to mechanism. We agree that 
the protection was not solely an anticoagulating 
effect. We had some animals in which the citrate 
was administered systemically and which had 
normal clotting times when the kidneys were still 
surviving. We had difficulty measuring comple-
ment and had to rely on a test for measuring 
the lysis of red blood cells and the inhibition of 
this effect through the immune mediators, com-
plement and antibody. 
We concluded that divalent cations were being 
chela ted by the citrate and that this was about 
one-fifth that of the controls. However, the in-
crease in survival time was twentyfold, so we 
concluded that perhaps there was also another 
mechanism at work; this was through an anaphy-
laxotoxin which was byproduct of C'5 and has 
no cytolytic effect, but rather a vasostressing ef-
fect. 
Finally, we too encountered problems with 
citrate toxicity. We could control them to some 
degree, so that we could get over a liter of 
citrate into large dogs by monitoring blood pres-
sure. We also found that giving intravenous digi-
talis was a very effective way of inhibiting the 
citrate effect, once it had been established, or 
preventing it if we gave it ahead of time. 
Dr. Jerry C. Rosenberg (Detroit, Mich.). I 
too am very impressed with this study. However, I 
am troubled by your failure to observe an ef-
fect by the citrate on the entrapment of formed 
blood elements and other substances within the 
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kidney. I would have thought that the entrap-
ment was partly responsible for the great decrease 
in blood flow that characterizes hyperacutc rejec-
tion. Yet Dr. Kux's findings are indirect cvi-
dence against that view. I think his report is 
going to start a whole new series of experiments. 
Dr. Matthias Kux. Thank you very much for 
your remarks, Dr. Linn, Dr. Rosenberg. We have 
done other studies where we have used the 
Mayan pit viper venom, which reduces thc 
fibrinogen content of the animal to zero. With 
fibrinogens of zero, we have had hyperacute re-
jection of pig-to-dog renal heterografts; which is 
somewhat of a negative proof that coagulation is 
not necessary for this process. But Dr. Linn's 
observation that a normal coagulation rejection 
could be delayed or prevented by citrate is very 
interesting. Even so, citrate has so many effects 
that we cannot, at present, single out the most 
important, or one single, effect responsible for 
protection. 
The protective effect of the digitalis drug, 
ouabain, against the deleterious effect on the 
heart of hypocalcemia may be important in per-
mitting citrate therapy to be tried clinically. 
Chairman Starzl. Excuse me, Dr. Kux. I have 
the distinct impression that you did not answer 
Dr. Rosenberg's question. He would like to have 
yuu explain the failure of citrate to alIect the 
gradients of various substances. 
Dr. Kux. Our inability to measure changes in 
the trapping of leukocytes, platelets, and other 
things was very surprising for us, too. I observed 
the same incongruity in isolated perfused lungs 
which we exposed to endotoxin. With endotoxin, 
the same trapping phenomenon persists, but the lung 
is spared from morphologic damage. Moreover, 
there is no increase in vascular resistance. I do 
not havc a satisfactory explanation for these find-
ings either in the heterograft or endotoxin experi-
ments and only wished to point out the similarity 
of the observations under both circumstances. 
Dr. John S. Najarian (Minneapolis, Minn.). 
There are two comments I would like to make. 
First, the essential feature of both the hypersensi-
tized homograft and the heterograft models is 
that you havc performed antigraft antibody in 
your recipient. There may be quantitative differ-
ences but successful therapy in one model should 
work for the other; Dr. Kux's paper has illustrated 
this. 
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Second, I would like to comment about the 
diminished whole complement consumption at the 
same time as unaltered trapping. Trapping occurs 
as the sequence of complement activation goes 
on to C'3, at which stage you get immune adher-
ence, which is primarily responsible for trapping. 
In your study, you measured complement with a 
red cell lysis system, which depends on the twelve-
point sequence of complement. Complement in-
hibition could have occurred at any time after 
C'3, but unless you do complement fragments, 
you are not going to be able to know this. 
Dr. Sakai (Rochester, N. Y.). We have done 
experiments in which kidneys were transplanted 
from puppies, guinea pigs and rabbits to rats. 
The rapidity of rejection was found to be related 
to the presence or strength of antibodies in the 
recipient directed against donor kidney cells. Have 
you looked for anti-pig kidney antibodies in your 
dog? Incidentally, we were able to prolong the 
survival of our xenografts by giving daily doses of 
heparin. 
Chairman Starz!' It has been known for some 
time that the dog is an intensely hostile recipient 
of organs from a variety of heterograft donors, 
including the rabbit and the pig. One of the dis-
cussants here-Dr. John Najarian-was the first 
to, if not establish, at least theorize that the rea-
son for this natural hostility was the presence 
of cytotoxic antibodies. In a paper he published 
about five years ago, he showed that these cyto-
toxins were directed against pig kidney cells. This 
fact was the basis for Dr. Najarian's comments 
a few moments ago about the possibility that these 
two experimental situations, the hypersensitized 
homograft model and the heterograft model, were 
probably the same or similar from the experimen-
talist's point of view; this would be, and probably 
is, a fortunate circumstance in which it is un-
necessary to presensitize to homografts in order 
to test certain kinds of therapy because you can 
have the same thing in a natural experiment of 
natu:'e. 
Dr. Kux (closing). One question of Dr. Naja-
rian's has not been answered. I agree we have to 
measure components of complement to know why 
the trapping phenomenon occurs. We have tried 
to measure complement components, but it is 
difficult in the dog. 
